Name | Number of supported studies | Average coverage | |
---|---|---|---|
placental villous trophoblast | 3 studies | 53% ± 29% |
Insufficient scRNA-seq data for expression of SLC22A11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5284.10 | 89 / 89 | 85% | 47.32 | 768 / 901 |
liver | 92% | 30.87 | 209 / 226 | 49% | 9.83 | 197 / 406 |
intestine | 70% | 4.33 | 676 / 966 | 34% | 1.36 | 179 / 527 |
adrenal gland | 97% | 33.98 | 250 / 258 | 5% | 0.38 | 11 / 230 |
spleen | 97% | 22.96 | 233 / 241 | 0% | 0 | 0 / 0 |
ovary | 91% | 8.38 | 163 / 180 | 0% | 0.01 | 2 / 430 |
uterus | 86% | 10.05 | 147 / 170 | 2% | 0.09 | 11 / 459 |
pancreas | 83% | 18.50 | 271 / 328 | 5% | 0.08 | 9 / 178 |
thymus | 86% | 8.97 | 564 / 653 | 0% | 0 | 0 / 605 |
prostate | 83% | 7.64 | 204 / 245 | 1% | 0.03 | 7 / 502 |
breast | 72% | 8.98 | 332 / 459 | 1% | 0.02 | 13 / 1118 |
brain | 73% | 4.95 | 1932 / 2642 | 0% | 0 | 0 / 705 |
lung | 66% | 4.76 | 384 / 578 | 3% | 0.09 | 36 / 1155 |
bladder | 52% | 5.71 | 11 / 21 | 14% | 1.04 | 69 / 504 |
stomach | 33% | 1.24 | 118 / 359 | 30% | 1.38 | 87 / 286 |
adipose | 61% | 3.54 | 735 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 60% | 3.40 | 805 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 44% | 1.78 | 640 / 1445 | 8% | 0.24 | 14 / 183 |
skin | 46% | 1.67 | 825 / 1809 | 1% | 0.07 | 6 / 472 |
heart | 44% | 2.17 | 377 / 861 | 0% | 0 | 0 / 0 |
muscle | 41% | 1.54 | 331 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 28% | 0.92 | 261 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046415 | Biological process | urate metabolic process |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0015732 | Biological process | prostaglandin transport |
GO_0015711 | Biological process | organic anion transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0015698 | Biological process | inorganic anion transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0015132 | Molecular function | prostaglandin transmembrane transporter activity |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015347 | Molecular function | sodium-independent organic anion transmembrane transporter activity |
GO_0005452 | Molecular function | solute:inorganic anion antiporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC22A11 |
Protein name | Solute carrier family 22 member 11 Solute carrier family 22 member 11 (Organic anion transporter 4) (OAT4) (Organic anion:dicarboxylate exchanger OAT4) |
Synonyms | OAT4 |
Description | FUNCTION: Antiporter that mediates the transport of conjugated steroids and other specific organic anions at the basal membrane of syncytiotrophoblast and at the apical membrane of proximal tubule epithelial cells, in exchange for anionic compounds . May be responsible for placental absorption of fetal-derived steroid sulfates such as estrone sulfate (E1S) and the steroid hormone precursor dehydroepiandrosterone sulfate (DHEA-S), as well as clearing waste products and xenobiotics from the fetus . Maybe also be involved in placental urate homeostasis . Facilitates the renal reabsorption of organic anions such as urate and derived steroid sulfates . Organic anion glutarate acts as conteranion for E1S renal uptake . Possible transport mode may also include DHEA-S/E1S exchange . Also interacts with inorganic anions such as chloride and hydroxyl ions, therefore possible transport modes may include E1S/Cl(-), E1S/OH(-), urate/Cl(-) and urate/OH(-) . Also mediates the transport of prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) and may be involved in their renal excretion . Also able to uptake anionic drugs, diuretics, bile salts and ochratoxin A . Mediates the unidirectional efflux of glutamate and aspartate . Glutamate efflux down its transmembrane gradient may drive SLC22A11/OAT4-mediated placental uptake of E1S . . |
Accessions | ENST00000377585.7 [Q9NSA0-2] ENST00000377581.7 ENST00000301891.9 [Q9NSA0-1] H7C3R9 H7C0B7 ENST00000428570.1 ENST00000416590.1 Q9NSA0 A6NCG2 |